Last reviewed: June 26, 2026
Last updated: June 26, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide works through a gradual dose escalation protocol, starting at 0.25 mg weekly and increasing every 4 weeks until reaching your therapeutic dose. Most patients reach their target weight loss dose between 1.0 mg and 2.4 mg weekly, but the timeline depends on individual tolerance, appetite suppression response, and metabolic factors.
How Semaglutide Dose Increases Work Over Time
Semaglutide treatment begins with a starter dose of 0.25 mg injected once weekly. This introductory phase allows your gastrointestinal system to adapt to the medication's effects on appetite signals and digestion. After one week at this dose, most people report reduced hunger and earlier satiety at meals, signaling that the drug has begun working.
Every four weeks, your dose typically increases by 0.25 mg if you tolerate the current level well. This stepwise approach—0.25 mg, 0.5 mg, 0.75 mg, 1.0 mg, 1.5 mg, 2.0 mg, and sometimes 2.4 mg—gives your body time to adjust while building toward maximum effectiveness. The four-week interval matters because it takes approximately that long for your body to reach steady-state drug levels and for you to accurately assess how you feel at each step.
Signs Your Body Is Ready for the Next Dose
Your healthcare provider monitors several indicators to determine if dose escalation is appropriate. These include your appetite level (whether hunger has remained suppressed), gastrointestinal tolerance (nausea, vomiting, or constipation severity), weekly weight loss progress, and how you feel overall energy-wise. If you're experiencing unmanageable side effects, your dose may hold steady or increase more slowly than the standard schedule.
Physical readiness signals include stable or improving nausea levels, consistent appetite suppression lasting the full week, and the ability to maintain adequate nutrition despite reduced food intake. Some people reach their optimal dose at 1.0 mg and maintain excellent results there, while others need 1.5 mg or higher for target weight loss. There is no universal 'right dose'—only the dose that works best for your individual metabolism and goals.
Why Your Dose Might Not Follow the Standard Timeline
Certain medical conditions, medications you take, or genetic factors can slow or speed how your body metabolizes semaglutide. Patients with kidney or liver disease, those taking medications that interact with GLP-1 drugs, or individuals with a history of medullary thyroid cancer may require modified escalation schedules. Your provider will adjust timing based on your health profile to keep you safe while achieving results.
Weight loss response also varies by genetic predisposition. The Precision Peptide Genetic Test offered by PlexusDx analyzes variants in GLP1R, GIPR, FTO, and MC4R genes—markers that influence how your body responds to GLP-1 therapy at the peptide pathway level. Understanding your genetic profile helps your provider predict whether you'll need lower or higher doses to achieve meaningful weight loss, and whether you're more likely to experience specific side effects at certain dose levels.
Balancing Dose Increases with Side Effect Management
Nausea is the most common side effect during dose escalation, typically peaking a few days after injection and subsiding within the week. Mild-to-moderate nausea often decreases as your body adapts, but severe nausea that interferes with eating or hydration requires provider attention. Strategies like eating smaller meals, avoiding fatty or greasy foods, and staying hydrated can reduce nausea intensity while your body adjusts to each new dose.
If you experience severe side effects, your provider may recommend staying at your current dose longer, slowing the escalation schedule, or even reducing back one step before progressing again. This isn't failure—it's precision dosing. The goal is reaching a dose that delivers weight loss results while keeping you feeling well enough to maintain the treatment long-term. PlexusDx compounded semaglutide injections start at $149 monthly, and your dose may need to go up, but your price won't as you find your optimal therapeutic level.
When to Hold or Delay Your Next Dose Increase
Certain situations warrant pausing or delaying dose escalation. These include acute illness (infection, gastroenteritis, surgery), significant dehydration, suspected or confirmed pregnancy, or changes in other medications that affect GLP-1 absorption. Your provider will guide you through holding your current dose until the situation resolves, then resuming the escalation schedule from where you paused.
Unplanned weight loss exceeding 2-3 pounds per week at any single dose level may signal that escalation should pause. While rapid initial weight loss is common in the first 4-6 weeks, sustained very-rapid loss can increase risk of gallstones and muscle loss. Your provider monitors your weight loss velocity and may recommend holding at your current dose longer to maintain a sustainable 1-2 pound weekly loss as the optimal rate for long-term success.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How long should I stay at each semaglutide dose before going up?
The standard protocol is four weeks at each dose level before escalating, but this timeline can extend if you need more adjustment time or experience side effects. Your provider makes the final decision based on your tolerance, weight loss progress, and overall health status.
What if I skip a dose increase or choose to stay at a lower dose?
Staying at a lower dose is medically safe if that's where you achieve good weight loss and feel well. Some patients reach their goal at 0.75 mg or 1.0 mg and see no benefit in going higher. Your treatment plan should be customized to your results and comfort level, not a predetermined endpoint.
Can I get semaglutide from PlexusDx without committing to multiple dose increases?
Yes. PlexusDx compounded semaglutide injections are available from licensed 503A pharmacies with no membership fee or insurance requirement, and you can adjust or pause treatment anytime. Your dose may need to go up, but your price stays at $149 per month regardless of which dose level you're using.
How do I know if genetic testing would help predict my dose needs?
If you're starting semaglutide with PlexusDx, the Precision Peptide Genetic Test ($99 add-on after your first month) analyzes how your genes influence GLP-1 and GIP receptor sensitivity, appetite hormones, and metabolic factors. This insight helps your provider anticipate whether you're a lower-dose responder or someone who needs higher doses, and may help predict side effect risk.
What happens if I experience severe side effects during dose escalation?
Contact your provider immediately. They may recommend holding at your current dose longer, extending the interval between increases from four weeks to six or eight weeks, or temporarily stepping back one dose level. Severe side effects are manageable through adjusted timing and don't mean semaglutide won't work for you.
Is there a maximum dose of semaglutide, and does everyone reach it?
The maximum therapeutic dose is 2.4 mg weekly, but many patients achieve their best results at 1.0 to 1.5 mg and never need to escalate further. Your optimal dose is the lowest amount that delivers the weight loss and appetite control you want while keeping side effects tolerable.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Why Ozempic Is Not Working: Navigating Your Weight Loss Path
Understanding the Side Effects of Wegovy: What Percentage of People Experience Them?